121 related articles for article (PubMed ID: 2534361)
1. Synthesis of tripeptide chloromethyl ketones and examination of their inhibitory effects on plasmin and plasma kallikrein.
Tsuda Y; Teno N; Okada Y; Wanaka K; Bohgaki M; Hijikata-Okunomiya A; Okamoto U; Naito T; Okamoto S
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3108-11. PubMed ID: 2534361
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
Odake S; Kam CM; Powers JC
J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
[TBL] [Abstract][Full Text] [Related]
3. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
Tans G; Janssen-Claessen T; Rosing J; Griffin JH
Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein.
Kettner C; Shaw E
Biochemistry; 1978 Oct; 17(22):4778-84. PubMed ID: 728386
[TBL] [Abstract][Full Text] [Related]
5. Development of selective inhibitors against plasma kallikrein.
Teno N; Wanaka K; Okada Y; Tsuda Y; Okamoto U; Hijikata-Okunomiya A; Naito T; Okamoto S
Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2930-6. PubMed ID: 1839246
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of plasmin substrates and relationship between their structure and plasmin activity.
Okada Y; Tsuda Y; Teno N; Wanaka K; Sasaki K; Hijikata A; Naito T; Okamoto S
Int J Pept Protein Res; 1986 Jan; 27(1):79-85. PubMed ID: 2936691
[TBL] [Abstract][Full Text] [Related]
7. Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinases.
Collen D; Lijnen HR; De Cock F; Durieux JP; Loffet A
Biochim Biophys Acta; 1980 Sep; 615(1):158-66. PubMed ID: 6448639
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of serine proteinases by squash inhibitors.
Otlewski J; Zbyryt T; Krokoszyńska I; Wilusz T
Biol Chem Hoppe Seyler; 1990 Jul; 371(7):589-94. PubMed ID: 2145863
[TBL] [Abstract][Full Text] [Related]
9. Amino acids and peptides. XXXVI. Synthesis of enkephalin chloromethyl ketone and evaluation of its inhibitory activity against endopeptidase 22.19.
Taguchi H; Nishiyama Y; Camargo AC; Okada Y
Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):2038-9. PubMed ID: 8293527
[TBL] [Abstract][Full Text] [Related]
10. Development of active center-directed plasmin and plasma kallikrein inhibitors and studies on the structure-inhibitory activity relationship.
Teno N; Wanaka K; Okada Y; Taguchi H; Okamoto U; Hijikata-Okunomiya A; Okamoto S
Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1079-90. PubMed ID: 8370108
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of serine proteinases from human blood clotting system by squash inhibitor mutants.
Grzesiak A; Buczek O; Petry I; Szewczuk Z; Otlewski J
Biochim Biophys Acta; 2000 May; 1478(2):318-24. PubMed ID: 10825543
[TBL] [Abstract][Full Text] [Related]
12. Studies of 2 -macroglobulin in bovine plasma. 3. Its actions on bovine plasma kallikrein, plasmin and thrombin.
Sugihara H; Nagasawa S; Suzuki T
J Biochem; 1971 Oct; 70(4):649-58. PubMed ID: 4257424
[No Abstract] [Full Text] [Related]
13. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
Bock PE
Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
[TBL] [Abstract][Full Text] [Related]
14. Serine protease specificity for peptide chromogenic substrates.
Mattler LE; Bang NU
Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of -guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin.
Muramatu M; Fujii S
Biochim Biophys Acta; 1972 Apr; 268(1):221-4. PubMed ID: 4259678
[No Abstract] [Full Text] [Related]
16. Development of plasma kallikrein selective inhibitors.
Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
[TBL] [Abstract][Full Text] [Related]
17. New leupeptin analogues: synthesis and inhibition data.
McConnell RM; Barnes GE; Hoyng CF; Gunn JM
J Med Chem; 1990 Jan; 33(1):86-93. PubMed ID: 2136920
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of potent and selective inhibitors of human plasma kallikrein.
Garrett GS; McPhail SJ; Tornheim K; Correa PE; McIver JM
Bioorg Med Chem Lett; 1999 Feb; 9(3):301-6. PubMed ID: 10091673
[TBL] [Abstract][Full Text] [Related]
19. [A substrate inhibitor analysis of the urinary excretion of tissue and plasma kallikreins in patients with chronic glomerulonephritis].
Platonova LV; Poliantseva LR; Filatova MP; Paskhina TS
Urol Nefrol (Mosk); 1990; (4):38-43. PubMed ID: 2275058
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones.
Lijnen HR; Uytterhoeven M; Collen D
Thromb Res; 1984 Jun; 34(5):431-7. PubMed ID: 6234678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
